A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/13 (2006.01)
Patent
CA 2540921
The invention relates to the use of NMDA receptor antagonists such as 1- aminocyclohexane derivatives to modify deposition of potentially toxic and fibrillogenic A.szlig. peptides in amyloidopathies. Specifically, the invention relates to the ability of memantine to intervene in the processing of APP and decrease the levels of fibrillogenic A.szlig. peptides.
L'invention se rapporte à l'utilisation d'antagonistes des récepteurs NMDA, tels que des dérivés de 1-aminocyclohexane, pour modifier le dépôt de peptides A.beta. fibrillogènes et potentiellement toxiques dans des amyloïdopathies. L'invention se rapporte spécifiquement à la capacité de la mémantine à jouer un rôle dans le traitement de l'APP et à réduire les taux de peptides A.beta. fibrillogènes.
Banerjee Pradeep
Farlow Martin R.
Gupta Sandeep
Lahiri Debomoy K.
Merz Pharma Gmbh & Co. Kgaa
Perley-Robertson Hill & Mcdougall Llp
LandOfFree
The use of 1-aminocyclohexane derivatives to modify... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with The use of 1-aminocyclohexane derivatives to modify..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of 1-aminocyclohexane derivatives to modify... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1724811